XML 60 R49.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
May 12, 2020
May 31, 2018
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2020
Sep. 30, 2020
Jan. 01, 2020
May 13, 2016
2016 Incentive Plan                  
Class of Stock [Line Items]                  
Number of shares authorized (in shares)     18,000,000       18,000,000   18,000,000
Number of potential shares authorized for issuance under share based compensation plan (in shares)                 2,000,000
Increase in number of shares authorized (in shares)               2,000,000  
Number of shares available for grant (in shares)     6,785,707       6,785,707    
Number of shares of unvested restricted stock units and options outstanding (in shares)     2,586,915       2,586,915    
Common stock, other shares, outstanding (in shares)     5,878,252       5,878,252    
Award vesting period (in years)             3 years    
Maximum contractual term (in years)             10 years    
2007 Incentive Plan                  
Class of Stock [Line Items]                  
Common stock, other shares, outstanding (in shares)     3,412,095       3,412,095    
Award vesting period (in years)             3 years    
Maximum contractual term (in years)             10 years    
Series C Preferred Stock                  
Class of Stock [Line Items]                  
Conversion of stock, shares converted (in shares)           14      
Common stock                  
Class of Stock [Line Items]                  
Conversion of stock, shares issued (in shares)           5,147      
Common stock | Prior Sales Agreement                  
Class of Stock [Line Items]                  
Maximum authorized amount   $ 100,000,000.0     $ 250,000,000.0        
Remaining authorized amount         $ 0        
Aggregate number of shares issued (in shares)         43,148,952        
Stock sale agreement weighted average price per share         $ 4.92        
Aggregate proceeds         $ 208,200,000        
Common stock | New Sales Agreement                  
Class of Stock [Line Items]                  
Maximum authorized amount $ 250,000,000.0           $ 126,400,000    
Agent fee 3.00%                
Aggregate number of shares issued (in shares)     0 12,041,178          
Stock sale agreement weighted average price per share       $ 10.26          
Aggregate proceeds       $ 121,700,000